Price
$59.33-2.53%Social Signal Score
Analyst Ratings
18 analystsRevenue
$12.33B+355.48%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Tadeu Luiz Marroco
- Sector
- Consumer Defensive
- Industry
- Tobacco
- Employees
- 47,797
- Beta
- 0.13
- Country
- GB
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.08
Financials
Revenue
$12.33B+355.5%Net Income
$3.21B+612.5%EBITDA
$6.08B+614.9%Free Cash Flow
$2.47B+24.7%EPS (diluted)
$1.46+143.3%Shares Outstanding (diluted)
2.18B-52.0%Operating Expenses
$2.67BCash & Debt
$2.53BReturn of Capital
$3.41BRevenue by Segment (annual)
$21.99BDividend per Share
$0.83Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $25.61B | $7.76B | $3.51 |
| 2024 | $25.87B | $3.07B | $1.37 |
| 2023 | $27.28B | $-14.37B | $-6.49 |
| 2022 | $27.66B | $6.67B | $2.93 |
| 2021 | $25.68B | $6.80B | $2.97 |
| 2020 | $25.78B | $6.40B | $2.80 |
| 2019 | $25.88B | $5.70B | $2.50 |
| 2018 | $24.49B | $6.03B | $2.68 |
| 2017 | $19.56B | $37.53B | $18.34 |
| 2016 | $14.13B | $4.65B | $2.50 |
| 2015 | $12.54B | $4.29B | $2.31 |
| 2014 | $13.97B | $3.12B | $1.67 |
| 2013 | $15.26B | $3.90B | $2.05 |
| 2012 | $15.19B | $3.84B | $1.98 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from BTI's reported EPS growth of 4.5% a year over 13 years.
- EPS in 5 years
- $4.42
- Implied price
- $53.09
- Return from $52.64
- 0.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $26.39 — -49.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 8 | 10 | 12 | 14 | 16 |
|---|---|---|---|---|---|
| -5.5% | -16.5% | -12.7% | -9.4% | -6.6% | -4.1% |
| -0.5% | -12.1% | -8.0% | -4.6% | -1.6% | 1.0% |
| 4.5% | -7.6% | -3.4% | 0.2% | 3.3% | 6.1% |
| 9.5% | -3.2% | 1.2% | 5.0% | 8.2% | 11.2% |
| 14.5% | 1.2% | 5.8% | 9.8% | 13.2% | 16.3% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+0.00%Social Signal Score
Mentions (13)
- Newsseekingalpha.com·1d ago·Positive
BTI: This Retracement Hands Income Investors A Fresh Opening Yielding 6.31% British American Tobacco trades at 11x 2026 earnings with a 6.31% yield, despite strong operational progress and robust free cash flow guidance. BTI's New Category revenue grew 18% with contribution margin rising to 13.8%, and Velo now leads the global Modern Oral market. Management reaffirmed 2030 targets: 3–5% revenue growth, 4–6% APFO growth, 5–8% EPS growth, and over £50 billion FCF from 2024–2030.
View source ↗ - Newsseekingalpha.com·2d ago·Neutral
…etition/Legal Risks Ahead A diversified combustible portfolio across premium, value, and discount positioning along with high-growth vapor/oral offerings underscores BTI's future resilience amid secular declines. H2'26 may deliver expanded US total nicotine volume shares, given the upcoming launches of Velo with higher strengths/limited edition flavors and Vuse Pro's fruit-flavored pods. The recent stock price meltdown triggers BTI's discounted P/E of 11.13x, richer forward dividend yields of 6.…
View source ↗ - Newsseekingalpha.com·3d ago·Positive
British American Tobacco p.l.c. (BTI) Analyst/Investor Day Transcript British American Tobacco p.l.c. (BTI) Analyst/Investor Day Transcript
View source ↗ - News247wallst.com·5d ago·Neutral
BTI vs. PM: Which Tobacco Dividend Will Actually Survive the Industry's Decline? Both BTI and PM fund generous dividends from a shrinking cigarette business, but one company's smoke-free pivot has already changed what its payout is built on, and that gap matters far more than the headline yield difference.
View source ↗ - Newsmarketbeat.com·6d ago·Positive
British American Tobacco Targets Smokeless Growth, £50B Cash Flow by 2030 British American Tobacco NYSE: BTI outlined its Horizon 2030 strategy at its 2026 Capital Markets Day, targeting growth in smokeless nicotine products while maintaining combustibles as a cash-generating business that funds investment, dividends and share buybacks.
View source ↗ - Newsmarketbeat.com·6d ago·Neutral
British American Tobacco Targets Horizon 2030 Growth With Velo, U.S. Turnaround and AI British American Tobacco NYSE: BTI used its 2026 Capital Markets Day to outline its Horizon 2030 strategy, emphasizing growth in modern oral nicotine products, a turnaround in the U.S. business, continued cash generation from combustibles and greater use of artificial intelligence across operations.
View source ↗ - Newsmarketbeat.com·6d ago·Negative
British American Tobacco Targets 3%-5% Growth as Smokeless Push Powers Horizon 2030 British American Tobacco NYSE: BTI used its Horizon 2030 Capital Markets Day in Winston-Salem, North Carolina, to outline plans to expand its smokeless portfolio, advocate for tobacco harm reduction regulation and deliver growth, margin expansion and shareholder returns through 2030.
View source ↗ - News247wallst.com·18d ago·Neutral
4 Tobacco Stocks Turning Huge Cash Flow Into High-Yield Dividends Tobacco companies spend almost nothing on new equipment yet generate billions in cash, and a handful of US-listed names funnel that surplus straight into shareholder pockets through yields that most sectors cannot touch.
View source ↗ - Newsfool.com·19d ago·Positive
4 High-Yield Dividend Stocks to Own for the Next Decade British American Tobacco, Verizon, Income Realty, and Energy Transfer are top dividend stocks to buy and hold.
View source ↗ - Newszacks.com·24d ago·Neutral
3 Tobacco Stocks to Watch Amid Changing Industry Dynamics PM, BTI and MO are navigating volume pressure and rising costs by expanding smoke-free portfolios and adapting to shifting consumer demand.
View source ↗ - Newsseekingalpha.com·33d ago·Positive
British American Tobacco: A Long-Term Perspective On This 6% Yielder British American Tobacco's Modern Oral segment grew 65.9% in H1'26 and is now the company's largest New Category while holding a 39.2% volume share in top markets. Sweden, Norway, Poland, and the US show how oral nicotine expands the pool of users as cigarettes decline. A reverse DCF shows that the shares at $55 look to price Modern Oral at a mere 16% CAGR, while this segment has been compounding at 47-66% recently.
View source ↗ - Newsbusinesswire.com·55d ago·Neutral
ITC Infotech Strengthens Strategic Tech Partnership With British American Tobacco (BAT) in New Multi-year Mandate BANGALORE, India & LONDON--(BUSINESS WIRE)---- $ITC #AI--ITC Infotech today announced a landmark multi-year strategic technology deal with British American Tobacco (BAT).
View source ↗ - Newsseekingalpha.com·59d ago·Positive
British American Tobacco Isn't Cheap Enough To Justify The Risk British American Tobacco remains a 'hold' as deteriorating fundamentals and limited upside outweigh growth in modern oral products. BTI's New Categories, particularly Velo and Vuse, are delivering strong market share gains, but core combustibles face long-term decline. Despite revenue growth, net income and EBITDA declined; cost-cutting and share buybacks are central to management's strategy.
View source ↗
Earnings
Thu, Feb 11(in 4 months)
Consensus estimate $2.63 per share
Typical surprise +2.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$2.25 vs $2.21beat
- Thu, Feb 12$2.55 vs $2.50beat
- Thu, Jul 31$2.79 vs $2.24beat
- Thu, Feb 13$2.50 vs $2.44beat
- Thu, Jul 25$2.55 vs $2.19beat
- Thu, Feb 8$2.45 vs $2.49miss
Estimates and results for BTI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BTI officers and directors.
No open-market trades in the recent filings. All 1 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
1 further Form 4 entry is share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Alan Armstrongsenate · disclosed Jul 21, 2026 (113d later)Buy$15,001 - $50,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (57d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (50d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$50,001 - $100,000
- Daniel Goldmanhouse · NY10 · disclosed Mar 20, 2023 (21d later)Buy$15,001 - $50,000
- Daniel Goldmanhouse · NY10 · disclosed Feb 24, 2023 (42d later)Sell$50,001 - $100,000
- Virginia Ann Foxxhouse · NC05 · disclosed Jan 3, 2023 (280d later)Buy$15,001 - $50,000
- Virginia Ann Foxxhouse · NC05 · disclosed Jan 3, 2023 (278d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed Dec 6, 2022 (34d later)Sell$50,001 - $100,000
- Virginia Ann Foxxhouse · NC05 · disclosed Sep 8, 2022 (16d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed Aug 5, 2022 (22d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed Aug 5, 2022 (7d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed Jul 5, 2022 (22d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed Jul 5, 2022 (5d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed May 4, 2022 (27d later)Buy$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed May 4, 2022 (8d later)Buy$15,001 - $50,000
- John Henry Rutherfordhouse · FL04 · disclosed Apr 19, 2022 (34d later)Sell$1,001 - $15,000
- Virginia Ann Foxxhouse · NC05 · disclosed Apr 5, 2022 (372d later)Buy$15,001 - $50,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.